home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

16.65 +0.19 (+1.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

22 23 Next >

Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗

September 26, 2023

Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...

Via Benzinga

NASDAQ: VTRS Shareholder Notice Investigation over Potential Wrongdoing by Certain Directors of Viatris Inc. ↗

September 22, 2023

San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Viatris Inc.are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase ↗

September 22, 2023

The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7."

Via Benzinga

Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks ↗

September 14, 2023

These stocks offer some mouth-watering payouts.

Via The Motley Fool

Viatris Stock: Bear vs. Bull ↗

August 31, 2023

This is a case where both sides have compelling arguments.

Via The Motley Fool

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris ↗

August 24, 2023

Via The Motley Fool

Where Will Viatris Be in 5 Years? ↗

August 18, 2023

Can this become a good growth business to invest in?

Via The Motley Fool

2 Beaten-Down Dividend Stocks to Buy ↗

August 11, 2023

These two stocks look like bargains right now for income investors.

Via The Motley Fool

3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗

September 09, 2023

Viatris, GSK, and Organon are all trading at less than 7 times earnings.

Via The Motley Fool

CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know ↗

September 01, 2023

CVS just fired a shot across Viatris' bow.

Via The Motley Fool

VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 22, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy? ↗

August 16, 2023

There are a few complicating factors that mean the generic form of the drug might not be a slam dunk.

Via The Motley Fool

If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today ↗

August 11, 2023

Would you have been better off investing in the S&P 500?

Via The Motley Fool

Topics Stocks

Is Viatris Stock Good for Dividend Income? ↗

August 09, 2023

If you keep your expectations in check, it could be a great pick.

Via The Motley Fool

A Preview Of Viatris's Earnings ↗

August 04, 2023

Via Benzinga

Viatris Stock: Bull vs. Bear ↗

July 22, 2023

Viatris shares have declined in the double digits over the past few years.

Via The Motley Fool

Viatris Q2 Earnings Beat Estimates, Multiple Sclerosis Therapy Accepted For FDA Review ↗

August 07, 2023

Viatris Inc (NASDAQ: VTRS) reported Q2 FY23 sales of $3.91 billion, up 2% on a divestiture-adjusted operational basis, marginally higher the

Via Benzinga

Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday ↗

August 07, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years ↗

August 04, 2023

If you're patient and consistent, it won't be too hard to build up a revenue stream.

Via The Motley Fool

Daily Stock Analysis: Viatris ↗

July 20, 2023

Viatris Inc’s most recent $0.12 quarterly dividend, paid June 16th to shareholders of record May 23rd, equates to $0.48 annually to throw a yield of 4.58%.

Via Talk Markets

1 Reason I Wouldn't Buy This High-Yielding Dividend Stock ↗

July 20, 2023

Unless you're only in it for the dividend, you might be disappointed with this stock.

Via The Motley Fool

Better Pharma Buy: Viatris vs. Pfizer ↗

July 19, 2023

Both stocks look cheap today.

Via The Motley Fool

Better High-Yield Dividend Stock: Altria or Viatris? ↗

July 15, 2023

Which of these top income stocks is the better buy right now?

Via The Motley Fool

A Look Into Healthcare Sector Value Stocks ↗

July 17, 2023

Via Benzinga

VTRS DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Viatris Inc. Investors with Losses to Secure Counsel Before Important July 14 Deadline in Securities Class Action - VTRS

July 14, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

3 Reasons to Buy Viatris Stock, and 1 Reason to Sell ↗

July 14, 2023

This drugmaker could be a great stock to own over the coming years.

Via The Motley Fool

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Viatris Inc. (VTRS)

July 13, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

3 Healthcare Stocks With Healthy Dividends ↗

July 13, 2023

These pharmaceutical companies all combine relatively high dividends with safe payout ratios.

Via The Motley Fool

VTRS DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important July 14 Deadline in Securities Class Action - VTRS

July 12, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Viatris Inc.

July 11, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com